Text Size:
How We Help You Help Your Patients

PreserVision® contains the exact levels of nutrients recommended by the NEI to help reduce the risk of moderate-to-advanced AMD progression.*
*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

PreserVision is the most studied eye vitamin brand.§ In fact, it was the brand used in the last 5 years of the NEI's 10 year follow-on study.
§Based on AREDS and AREDS2 clinical studies

Call our hotline to request free patient samples and literature.
You can also learn more on our patient education site, SightMatters.
What is the OCUSorb™ Formula?
OCUSorb™ is a proprietary formulation of micronized lutein and zeaxanthin that has
been clinically shown to offer higher levels of absorption.*§ ‡

‡ Based on AUC of Lutein and Zeaxanthin compared
to original PreserVision AREDS 2 Soft Gel.

The OCUSorb™ formulation:
Is clinically-proven to increase bioavailability and absorption of lutein and zeaxanthin||
May help lead to enhanced deposition of lutein and zeaxanthin into the macula.
May be beneficial for your patients looking for improved absorption of ocular nutritional ingredients.
||Compared to the market sample, at p=0.05.
§Compared to original lutein and zeaxanthin in PreserVision AREDS 2 Formula Soft Gels
1. Kotagiri SR, Morde A, Rai D, et al. Superior bioavailability of a novel lutein and zeaxanthin formulation in healthy human subjects. Ophthalmol Ther. 2022;11(4):1463-1477.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
The Science
The NEI continues to study AREDS2 supplements in patients with moderate-to-advanced AMD. In 2022, the NEI published the results of the AREDS2 10 year follow-on study, contributing to over two decades of demonstrated data.
The AREDS Studies

The Supplement
PreserVision® contains the exact levels of nutrients recommended by the NEI to help reduce the risk of moderate-to-advanced AMD progression.* In fact, the NEI used PreserVision® in the last 5 years of its 10 year follow-on study.
Our FormulaRecommend PreserVision®
(We surveyed 200 optometrists and ophthalmologists)
Contains the exact nutrient formula recommended by the NEI to help lower the risk of moderate-to-advanced AMD progression.1*
PreserVision is the most studied eye vitamin brand.2
No side effects or tolerability issues reported in the AREDS trials.3 Published NEI AREDS2 data indicates no significant safety concerns and tolerability issues for the AREDS2 formula at 10 years.
1. Over 10 years, compared to placebo
2. Based on AREDS and AREDS 2 clinical studies
3. Two doses per day, every day
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Helping You Help Your Patients
How many minutes can you give to each AMD patient? Our patient education website and materials can help you offer maximum support.
For Your Patients
The One-stop Online Resource for Your AMD Patients
Patients want to preserve their vision, and they want to know how.
SightMatters provides info, tips and savings to make lifestyle changes easy.
Give them a helping hand: Recommend SightMatters.
Understanding AMD
and What to Expect
An Action Plan to
help preserve their vision
Tips for Living
with AMD
by Bausch + Lomb